SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Affymax, Inc. and Takeda Pharmaceutical Co. Ltd. Announce Analyses from OMONTYS® (peginesatide) Injection Phase 3 Dialysis Studies Presented at 2012 American Society of Nephrology Meeting